搜索临床试验以:GvHD (Graft versus Host Disease)
总计108973个结果
-
Mario Negri Institute for Pharmacological Research终止
-
Jeffrey BrowningNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
Assiut University尚未招聘
-
Umeå UniversityCounty Council of Norrbotten, Sweden; Norrlandstingens Regionförbund完全的
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)完全的
-
Mallinckrodt完全的
-
M.D. Anderson Cancer CenterCelgene Corporation终止
-
Peking University People's HospitalSun Yat-sen University; Third Military Medical University; Southern Medical University, China完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey完全的
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)未知移植物抗宿主病
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)撤销
-
Roswell Park Cancer Institute完全的
-
Massachusetts Eye and Ear InfirmaryOcular Therapeutix, Inc.撤销
-
Assistance Publique - Hôpitaux de ParisNational Research Agency, France未知
-
Dana-Farber Cancer Institute完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
University of Michigan完全的
-
Health NavigatorVastra Gotaland Region; Region Stockholm; Ostergotland County Council, Sweden; Uppsala County Council... 和其他合作者未知
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis完全的
-
Ohio State University Comprehensive Cancer Center撤销
-
Fundación Pública Andaluza para la gestión de la...Instituto de Salud Carlos III主动,不招人
-
Jennifer E. SchwartzMillennium Pharmaceuticals, Inc.完全的
-
Oncoimmune, Inc., a subsidiary of Merck & Co.,...National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio State University 和其他合作者完全的Efprezimod Alfa (CD24Fc, MK-7110) 用于预防清髓性同种异体造血干细胞移植 (HSCT) 后急性移植物抗宿主病 (GVHD) 的 II 期试验 (MK-7110-002)白血病 | 造血干细胞移植 | 移植物抗宿主病美国